Diagnostic evaluation and management of patients with syncope

Medical Clinics of North America

Volumn 85, Issue 2, 2001, Pages 423-456

  Schnipper, Jeffrey L ^a,b   Kapoor, Wishwa N ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIANGINA PECTORIS AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ATENOLOL; CANNABIS; COCAINE; DIGOXIN; EDROPHONIUM; ENALAPRIL; GLYCERYL TRINITRATE; INSULIN; ISOPRENALINE; MIDODRINE; PAROXETINE; VINCRISTINE;

ALGORITHM; CAROTID SINUS PRESSORECEPTOR REFLEX; CLINICAL EXAMINATION; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ECHOCARDIOGRAPHY; ELDERLY CARE; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; EXERCISE TOLERANCE; HEART ARRHYTHMIA; HEART PACING; HOLTER MONITORING; HOSPITALIZATION; HUMAN; MEDICAL DECISION MAKING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGIC ASSESSMENT; REVIEW; SYNCOPE; SYNDROME DELINEATION; TILT TABLE TEST;

EID: 0035111050     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70321-7     Document Type: Article

References (120)

1. Syncope and orthostatic hypotension
2. The duration of Holter monitoring in patients with syncope: Is 24 hours enough?
3. Syncope: A retrospective study of 101 hospitalized patients
4. Tilt table testing for assessing syncope. American College of Cardiology
5. Clinical approach to diagnosis of syncope: An overview
6. Superiority of 24-hour outpatient monitoring over multi-stage exercise testing for the evaluation of syncope
7. Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: A statement by a Task Force Committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology
8. Clinical features of adenosine sensitive syncope and tilt induced vasovagal syncope
9. Adenosine-induced atrioventricular block in patients with unexplained syncope: The diagnostic value of ATP testing
10. Neurally mediated syncope detected by carotid sinus massage and head-up tilt test in sick sinus syndrome
11. Carotid sinus massage, eyeball compression, and head-up tilt test in patients with syncope of uncertain origin and in healthy control subjects
12. Use of intravenous adenosine as a noninvasive diagnostic test for sick sinus syndrome
13. Pharmacologic approaches to therapy for vasovagal syncope
14. Comparison of responses to isoproterenol and epinephrine during head-up tilt in suspected vasodepressor syncope
15. The value of the clinical history in the differentiation of syncope due to ventricular tachycardia, atrioventricular block, and neurocardiogenic syncope
16. Arrhythmias detected by ambulatory monitoring: Lack of correlation with symptoms of dizziness and syncope
17. Role of invasive electrophysiologic testing in patients with symptomatic bundle branch block
18. The North American Vasovagal Pacemaker Study (VPS): A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope
19. Cardiac loop ECG recording: A new noninvasive diagnostic test in recurrent syncope
20. Transient ischemic attack-related syncope
21. Electroencephalography should not be routine in the evaluation of syncope in adults
22. Evaluation and outcome of emergency room patients with transient loss of consciousness
23. Clinical predictors of electrophysiologic findings in patients with syncope of unknown origin
24. Electrophysiologic studies in patients with unexplained syncope
25. Syncope in a population of healthy young adults
26. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: A randomized, double-blind, placebo-controlled study
27. Electrophysiologic studies in patients with unexplained syncope
28. Complications in patients undergoing cardiac electrophysiologic procedures
29. The impact of diagnostic tests in evaluating patients with syncope
30. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope
31. Personal and public safety issues related to arrhythmias that may affect consciousness: Implications for regulation and physician recommendations: A medical/scientific statement from the American Heart Association and the North American Society of Pacing and Electrophysiology
32. Vasovagal reactions may occur after orthotopic heart transplantation
33. Methodology of head-up tilt testing in patients with unexplained syncope
34. Utility and cost of event recorders in the diagnosis of palpitations, presyncope, and syncope
35. Syncope in the elderly
36. The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by transient bradycardia
37. Detection of late potentials on the surface electrocardiogram in unexplained syncope
38. Syncope in a general hospital patient population: Usefulness of the radionuclide brain scan, electroencephalogram, and 24-hour Holter monitor
39. Acute cardiac ischemia in patients with syncope: Importance of the initial electrocardiogram
40. Epidemiology of syncope in hospitalized patients
41. Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope
42. Decision to hospitalize: Objective diagnosis-related group criteria versus clinical judgment
43. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation)
44. Syncope and seizures of psychogenic origin: Identification with head-upright tilt table testing
45. Value and limitations of clinical electrophysiologic study in assessment of patients with unexplained syncope
46. Cardiovascular and catecholamine responses to head-up tilt in the diagnosis of recurrent unexplained syncope in elderly patients
47. Value and limitations of noninvasive assessment of syncope
48. Syncope and presyncope associated with probable adverse drug reactions
49. Syncope or seizure? The diagnostic value of the EEG and hyperventilation test in transient loss of consciousness
50. Transient loss of consciousness: The value of the history for distinguishing seizure from syncope
51. Risks and complications of clinical cardiac electrophysiologic studies: A prospective analysis of 1,000 consecutive patients
52. Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
53. Aortic stenosis, sudden death, and the left ventricular baroreceptors
54. Importance of Holter monitoring in patients with periodic cerebral symptoms
55. Ambulatory ECG recording in patients referred because of syncope or dizziness
56. Syncope in the elderly
57. Evaluation and outcome of patients with syncope
58. Workup and management of patients with syncope
59. Using a tilt table to evaluate syncope
60. Prolonged electrocardiographic monitoring in patients with syncope: Importance of frequent or repetitive ventricular ectopy
61. Psychiatric illnesses in patients with syncope
62. Diagnosis and natural history of syncope and the role of invasive electrophysiologic testing
63. Syncope of unknown origin: The need for a more cost-effective approach to its diagnosis evaluation
64. A prospective evaluation and follow-up of patients with syncope
65. Upright tilt testing in evaluating syncope: A comprehensive literature review
66. Head-up tilt: A useful test for investigating unexplained syncope
67. Carotid sinus syndrome - Clinical characteristics in elderly patients
68. Syncope in young adults: Evidence for a combined medical and psychiatric approach
69. The high cost of syncope: Cost implications of a new insertable loop recorder in the investigation of recurrent syncope
70. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators
71. Electrophysiologic testing in patients with unexplained syncope: Clinical and noninvasive predictors of outcome
72. Clinical utility of transthoracic two-dimensional and Doppler echocardiography
73. Signal-averaged electrocardiogram for evaluation of recurrent syncope
74. Evaluation of arrhythmic causes of syncope: Correlation between Holter monitoring, electrophysiologic testing, and body surface potential mapping
75. Occurrence of presyncope in subjects without ventricular innervation
76. Improved selection of patients for programmed ventricular stimulation by frequency analysis of signal-averaged electrocardiograms
77. Long-term outcome of patients with syncope associated with coronary artery disease and a nondiagnostic electrophysiologic evaluation
78. Psychiatric syncope: A new look at an old disease
79. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope
80. Predicting the outcomes of electrophysiologic studies of patients with unexplained syncope: Preliminary validation of a derived model
81. Diagnosing syncope: Part 1. Value of history, physical examination, and electrocardiography. Clinical Efficacy Assessment Project of the American College of Physicians
82. Diagnosing syncope: Part 2. Unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians
83. Syncope in institutionalized elderly: The impact of multiple pathological conditions and situational stress
84. Syncope in an elderly, institutionalised population: Prevalence, incidence, and associated risk
85. Valvular aortic stenosis: A clinical and hemodynamic profile of patients
86. Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results
87. Prospective evaluation of syncope
88. Risk stratification of patients with syncope
89. Outcome of an integrated approach to the investigation of dizziness, falls and syncope in elderly patients referred to a 'syncope' clinic
90. Clinical characteristics of vasodepressor, cardioinhibitory, and mixed carotid sinus syndrome in the elderly
91. Syncope of unknown origin: Clinical, noninvasive, and electrophysiologic determinants of arrhythmia induction and symptom recurrence during long-term follow-up
92. Electrophysiologic testing in bundle branch block and unexplained syncope
93. Can serial tilt testing be used to evaluate therapy in neurally mediated syncope?
94. Syncope-related trauma: Rationale and yield of diagnostic studies
95. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: Results of a controlled study of etilefrine versus placebo
96. Incidence of complications after carotid sinus massage in older patients with syncope
97. The signal-averaged electrocardiogram as a screening test for inducibility of sustained ventricular tachycardia in high risk patients: A prospective study
98. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial
99. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: A double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study
100. Echocardiography in the evaluation of patients with syncope
101. Electrophysiologic testing in patients with recurrent syncope: Are results predicted by prior ambulatory monitoring?
102. Evolution of patients with clinical neurocardiogenic (vasovagal) syncope not subjected to specific treatment
103. Epidemiologic features of isolated syncope: The Framingham Study
104. Role of pacing in the treatment of vasovagal syncope
105. Patients with syncope admitted to medical intensive care units
106. A cost effective approach to the investigation of syncope: Relative merit of different diagnostic strategies
107. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study
108. Unexplained syncope evaluated by electrophysiologic studies and head-up tilt testing
109. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole
110. Use of the signal-averaged electrocardiogram for predicting inducible ventricular tachycardia in patients with unexplained syncope: Relation to clinical variables in a multivariate analysis
111. Carotid sinus hypersensitivity and the carotid sinus syndrome
112. Midodrine: A role in the management of neurocardiogenic syncope
113. Role of ventricular vagal afferents in the vasovagal reaction
114. Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons
115. Signal averaging of the surface QRS complex predicts inducibility of ventricular tachycardia in patients with syncope of unknown origin: A prospective study
116. A cost-effectiveness strategy for transtelephonic arrhythmia monitoring
117. Cardiovascular complaints: Correlation with cardiac arrhythmias on 24-hour electrocardiographic monitoring
118. Randomized, double-blind, placebo-controlled trial of oral enalapril in patients with neurally mediated syncope
119. Utility of patient-activated cardiac event recorders in geneal clinical practice
120. The evolving role of ambulatory arrhythmia monitoring in general clinical practice